Related Experiment Video
Updated: Apr 20, 2026

07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
1.3K
Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines.
Tsui-Ting Ho1, Nanjiang Zhou1, Jianguo Huang1
1Department of Pharmacology/Toxicology and Cancer Institute, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Nucleic Acids Research
|November 22, 2014
Summary
CRISPR/Cas genome editing can now target non-coding genes in human cells. This study developed methods for efficient knockout of non-coding RNAs and lncRNAs, advancing gene editing applications.
Area of Science:
- Molecular Biology
- Genetics
- Gene Editing
Background:
- CRISPR/Cas is a powerful genome-editing tool, primarily used for protein-coding genes.
- Knocking out non-coding genes is challenging due to the lack of open reading frames and potential for functional redundancy, especially in polyploid human cell lines.
Purpose of the Study:
- To investigate the applicability of CRISPR/Cas genome editing for the functional knockout of non-coding genes in human cell lines.
- To develop and optimize strategies for efficient non-coding gene targeting using CRISPR/Cas technology.
Main Methods:
- Utilized a homologous recombination (HR) selection system for marker gene integration.
- Constructed a dual guide RNA vector to enable simultaneous double-strand breaks for large fragment deletion.
- Employed suppression of the non-homologous end joining (NHEJ) pathway to enhance HR-mediated targeting efficiency.
Main Results:
- Successfully generated knockouts for multiple non-coding RNAs (miR-21, miR-29a) and long non-coding RNAs (lncRNA-21A, UCA1, AK023948) in various human cell lines.
- Demonstrated that HR-mediated targeting efficiency is improved by suppressing the NHEJ pathway.
- Validated the feasibility of CRISPR/Cas-mediated knockout for diverse non-coding genetic elements.
Conclusions:
- The CRISPR/Cas system, when combined with HR and NHEJ suppression, is a feasible and effective tool for knocking out non-coding genes in human cell lines.
- This approach overcomes previous limitations in targeting non-coding genomic regions, expanding the utility of genome editing.
- The developed methods provide a robust platform for functional studies of non-coding RNAs and lncRNAs.
Related Concept Videos
CRISPR/Cas9 Genome Editing
3.4K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.4K
CRISPR
60.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
60.5K

